Good Manufacturing Practice, or GMP, is the universal standard for quality production. It is a set of rules to ensure that products like medicines, food, and medical devices are made consistently and safely, batch after batch. The central idea is simple: quality cannot be inspected into a product at the end of the line. Instead, it must be built into every step of the manufacturing process, from the raw materials that arrive at the loading dock to the final package that leaves it.
The “c” in cGMP stands for Current. This single letter introduces a critical, dynamic requirement. While GMP provides the foundational rulebook, cGMP legally obligates manufacturers to use the most up-to-date technologies, systems, and scientific understanding available today. A process that was perfectly acceptable under GMP standards a decade ago might fail a cGMP inspection now if better, more reliable methods have since emerged. It forces companies to continuously improve.
Key Takeaways
- GMP & cGMP distinction is now academic; the expectation is universal.
- Quality Risk Management (QRM) is the engine, not the paperwork nor the PLM.
- Data integrity is a primary audit focus.
- “Human Error” is a symptom, not a root cause. Attributing a deviation to “human error” is a red flag for a weak quality system.
- Process Analytical Technology (PAT) embodies the shift from testing to real-time assurance. The “c” in cGMP is exemplified by PAT.
- Supplier oversight is data-driven, not just audit-driven.
- The Qualified Person (QP) represents a critical EU-specific responsibility.
- The Contamination Control Strategy (CCS) is the new cornerstone of sterile manufacturing.
The 10 Core Principles of Good Manufacturing Practice (GMP)
GMP is not just a set of rules but a quality mindset built upon ten fundamental principles. These principles work together to create a robust system that ensures quality is built into a product at every stage, rather than merely being tested for at the end.
1. Write Step-by-Step Procedures and Work Instructions
The foundation of GMP is ensuring that all processes are clearly defined and documented. This principle requires creating detailed, unambiguous Standard Operating Procedures (SOPs) for every critical task. The goal is to ensure that operations are performed consistently and correctly every time, regardless of who is performing the task. This eliminates ambiguity and provides a clear reference for training and execution.
Example of application: a company, “PharmaBlend Inc.,” manufactures a temperature-sensitive liquid drug. Their SOP for “Compounding Tank Temperature Control” (SOP-MFG-101) specifies not just the target temperature (40°C ± 2°C), but also the exact sequence for starting the heating jacket, the rate of temperature increase (not to exceed 5°C per minute), the specific calibrated probe to use for monitoring, and the actions to take if the temperature overshoots.
Tip: instead of writing monolithic SOPs, use a modular approach. Create “master” SOPs for complex processes that reference smaller, task-specific “work instruction” documents for individual steps (e.g., calibrating a specific sensor, operating a single valve). This allows for easier updates—if a single piece of equipment is replaced, you only need to revise one small work instruction instead of the entire process SOP, significantly reducing review and approval time and minimizing the risk of introducing errors into unrelated sections.
2. Follow Procedures and Instructions Meticulously
Having documented procedures is meaningless if they are not followed. This principle demands strict adherence to the written SOPs without deviation. If a deviation is necessary, it must be formally documented, justified, and approved through a defined change control process. This ensures that any departure from the standard is controlled, assessed for risk, and recorded for traceability.
Tip: implement a “Right-First-Time” (RFT) metric for procedure execution, tracked during batch record review. When deviations occur due to non-adherence, don’t just retrain the operator. Perform a root cause analysis focused on the procedure’s usability (a Human Factors approach). Was the instruction ambiguous? Was the sequence illogical? Is the required tool hard to access? Improving the procedure itself is a more effective long-term Corrective and Preventive Action (CAPA) than simply blaming human error.
3. Promptly and Accurately Document Work
This is the principle of “if it wasn’t written down, it didn’t happen.” All activities, from receiving raw materials to shipping the final product, must be documented in real-time. This includes recording data, signatures, dates, and any observations. Accurate, contemporaneous documentation provides a complete and traceable history of a batch (known as a Batch Record or Device History Record), which is essential for investigating deviations, troubleshooting problems, and proving compliance during an audit.
Tip: when designing batch records (paper or electronic), incorporate “data integrity checks” directly into the fields. For example, instead of just a blank space for “End Time,” structure it to require a start time and an end time, with an automated or manual check to ensure the duration is logical for the process step. For critical entries, use “verify-by-second-person” sign-offs, but ensure the verifier is trained to re-perform the critical calculation or check the setting, not just “check the box.”
Difference between DMR and DHR:
- The Device Master Record, or DMR, is the master recipe for a medical device. It is a formal, controlled compilation of all the instructions, specifications, and procedures required to produce a consistent product. The DMR contains everything from the design drawings and material specifications to the detailed manufacturing instructions, quality control test methods, labeling, and packaging requirements. Think of it as the complete blueprint; it defines exactly how the device is supposed to be made, from start to finish.
- The Device History Record, or DHR, is the proof that a specific batch, lot, or individual unit was actually built according to that recipe. It is the completed production record. The DHR contains the specific dates of manufacture, quantities produced, test results for that batch, and traceability information like serial or lot numbers. While the DMR is the instruction manual that applies to all units, the DHR is the historical evidence that demonstrates one specific production run followed those instructions and met all acceptance criteria.
4. Validate Your Work & Process
Validation is the documented proof that a process, system, or piece of equipment consistently produces the expected result. This principle requires manufacturers to prove that their processes are reliable and under control. This includes validating manufacturing processes, analytical testing methods, cleaning procedures, and computerized systems to ensure they are fit for their intended purpose.
Tip: adopt a lifecycle approach to validation based on ASTM E2500. Instead of treating validation as a one-time event, integrate it with Quality by Design (QbD). Define a “control space” during process development, and use the validation exercise (Process Performance Qualification – PPQ) not just to confirm the process works, but to verify that it remains within this state of control. This shifts the focus from a simple pass/fail event to demonstrating ongoing process understanding and control, which is highly valued by regulators.
For this stage, we suggest our very complete reading on IQ OQ PQ Process Validation:
Expert tip: validation is becoming a continuous lifecycle, not a one-time event. The “three successful batches” mindset is becoming obsolete. cGMP demands a lifecycle approach to ensure the process remains in a state of control for its entire commercial life:
- a robust process design (Stage 1)
- formal qualification (Stage 2)
- and a program for Continued Process Verification (Stage 3)
5. Properly Design, Build, and Maintain Facilities and Equipment
The physical environment and the tools used are critical to product quality. This principle dictates that facilities must be designed to prevent cross-contamination and mix-ups. Equipment must be designed for its intended use, easy to clean, and properly calibrated and maintained.
The layout, airflow, and material flow should all be logically designed to protect the product such as unidirectional flow for personnel and materials. Raw materials enter one end, move through dedicated processing suites with positive air pressure differentials, and finished goods exit the other end. There are no crossing paths between raw and finished goods, and personnel must pass through airlocks to enter production areas, minimizing the risk of cross-contamination.
Tip: when designing a new facility or modifying an old one, use 3D modeling and virtual reality (VR) walkthroughs with a cross-functional team (including operators, maintenance, and QA) before construction begins. This allows you to identify ergonomic issues, inefficient material flows, and hard-to-clean areas (e.g., inaccessible pipework, awkward equipment placement) at the design stage, where changes are cheap, rather than after the facility is built, where they are prohibitively expensive.
6. Maintain Good Housekeeping and Hygiene
Contamination is a major risk in manufacturing. This principle requires maintaining a high level of cleanliness and hygiene throughout the facility. This includes personal hygiene standards for employees (e.g., proper gowning), documented cleaning and sanitation schedules for facilities and equipment, and pest control programs. The goal is to protect the product from physical, chemical, and microbial contaminants.
Example of application: the cleaning procedure for a mixing vessel is not just “wash with detergent.” It’s a validated, multi-step process: pre-rinse with purified water, wash with a specific concentration of a validated cleaning agent for a set time, final rinse with Water-For-Injection (WFI), and finally, a swab test for chemical and microbial residues to prove the vessel is truly clean before the next batch can be made.
Note: cleaning is different from disinfection (refer to other articles on this).
Tip: implement a robust environmental monitoring (EM) program that goes beyond routine sampling. Use EM data to create trend analysis charts and heat maps of your facility. A spike in microbial counts in one area isn’t just a deviation to be closed; it’s a data point. Use this data proactively to identify “hot spots,” assess the effectiveness of cleaning procedures over time, and adjust sanitation frequencies based on risk and data, rather than a fixed, arbitrary schedule.
7. Build Quality into the Entire Product Lifecycle
This principle emphasizes that quality is not just the responsibility of the Quality Control (QC) department. It must be integrated into every stage, from research and development, through raw material sourcing (supplier qualification), manufacturing, packaging, and distribution. It involves a holistic approach where every department understands its role in maintaining product quality.
Example of application: “Precision Pills LLC” is developing a new tablet. During the R&D phase (long before manufacturing), they use Quality by Design (QbD) principles. They identify Critical Quality Attributes (CQAs) like tablet hardness and dissolution rate. They then perform experiments to understand how Critical Process Parameters (CPPs) like turret speed and compression force affect these CQAs. This knowledge is then transferred to manufacturing, ensuring a robust and well-understood process from day one.
Tip: establish a formal Technology Transfer team that acts as a bridge between R&D, Engineering, and Manufacturing. This team should manage a “knowledge transfer package” that includes not just the process parameters, but the rationale behind them (the “why”). This package should detail failed experiments, process boundaries, and the scientific understanding of the product. This prevents manufacturing from treating the process like a “black box” and enables more effective troubleshooting and continuous improvement later on.
8. Perform Quality Control and Audits
An independent Quality unit (comprising Quality Assurance and Quality Control) is essential. This principle ensures that proper controls are in place. This includes testing raw materials, in-process samples, and finished products against pre-defined specifications. It also involves conducting regular internal audits (self-inspections) to assess the effectiveness of the GMP system and ensure it is being followed correctly.
Example of application: “SafeInjectables Corp.” receives a shipment of vials from a new supplier. Even though the supplier provided a Certificate of Analysis (CoA) showing the vials meet all specifications, the internal QC lab performs its own independent identity and critical defect testing (e.g., for cracks and dimensions) on a sample of the vials before the shipment is released for use in production. This verifies the supplier’s data and protects against potential quality issues.
Tip: structure your internal audit program to be process-based, not just department-based. Instead of auditing the “Warehouse Department,” conduct an audit of the “Material Control Process” which would follow the material from receiving, through warehouse storage, dispensing, and return-to-stock. This approach breaks down departmental silos and provides a much clearer picture of the health and efficiency of the end-to-end process, revealing risks that occur at the hand-off points between departments.
9. Protect Products Against Contamination
This is a central theme that overlaps with other principles but deserves its own focus. It involves designing processes and facilities to prevent contamination of the product with any foreign substance.
This includes preventing cross-contamination between different products, microbial contamination, and contamination from personnel or the environment.
Measures like closed production systems, proper gowning, and controlled material handling are key applications of this principle.
Example of application: a facility, “MultiHerb Supplements,” produces both a ginseng supplement and a potent herbal extract known to be an allergen. To prevent cross-contamination, the allergenic extract is produced in a completely segregated suite with its own dedicated air handling system (HVAC) and equipment. All tools are color-coded red and are never allowed to leave the suite. This physical and procedural separation is critical to protecting other products.
Tip: go beyond physical segregation and implement a “cleaning verification” strategy for shared equipment that is based on toxicological data. For each product, calculate the Permitted Daily Exposure (PDE) value. Use this PDE to establish a scientifically-justified, health-based cleaning limit for product residues. This risk-based approach is the current industry standard (promoted by EMA) and is far more robust than relying on older, arbitrary limits like “10 ppm” or “visibly clean.”
10. Train and Develop Competent Personnel
The human element is often the most critical and variable factor in manufacturing. This principle requires that all employees are properly trained for their specific roles. Training should cover not only the technical aspects of their job (how to operate equipment) but also the principles of GMP and the potential consequences of not following procedures. Competency must be regularly assessed and documented.
Example of application: before an operator at “CellTherapy Innovations” is allowed to work independently on the critical cell culture expansion step, they must complete a multi-stage qualification program. This includes reading SOPs, observing a qualified operator, performing the task under direct supervision, and finally, successfully processing several “test” batches on their own. Their competency is documented and certified by their supervisor and the QA department in their official training file ( mandatory in most of the sectors where GMP applies).
Tip: move from a simple “training-based” system to a “competency-based” one. Instead of just documenting that an operator was “trained” on an SOP, develop a formal competency assessment that requires them to demonstrate their skill and knowledge. This could involve a practical test (e.g., “correctly assemble and disassemble this filler pump”) and a verbal component (“explain to me the critical parameters of this step and what you would do if they deviated”). This creates a much more robust record of qualification and ensures true understanding, not just attendance.
Scope and Applications of GMP
The scope of GMP is broad, covering any industry where the quality of the product can have a significant impact on consumer health and safety. The application of GMP principles is tailored to the specific risks associated with each industry.
1. Pharmaceuticals and biotechnology Covers the manufacturing of all medicinal products, including prescription drugs, over-the-counter medications, vaccines, and Active Pharmaceutical Ingredients (APIs). This is the most stringent application of GMP. It involves strict control over raw materials, aseptic (sterile) processing for injectables, rigorous process validation, stability testing to determine shelf life, and a “Qualified Person” in the EU responsible for certifying that each batch meets all legal and quality requirements before release. Regulations like 21 CFR Part 211 (US) and EudraLex Volume 4 (EU) govern this sector. | 2. Medical devices Includes everything from simple tongue depressors to complex life-sustaining equipment like pacemakers and MRI machines. The focus is on design controls, ensuring the device is designed to be safe and effective from the outset. GMP for medical devices (often called the Quality System Regulation or QSR) emphasizes risk management (ISO 14971), traceability of components, and maintaining a complete Device Master Record (DMR) and Device History Record (DHR). The key regulation in the US is 21 CFR Part 820. |
3. Food and beverage Covers the processing, packaging, and holding of human food. GMP in the food industry focuses on preventing contamination and ensuring food safety. Key applications include Hazard Analysis and Critical Control Points (HACCP) systems to identify and control food safety hazards, allergen management programs to prevent cross-contact, sanitation procedures, and pest control. The Food Safety Modernization Act (FSMA) in the US heavily incorporates cGMP principles. |  |
4. Cosmetics Includes products like makeup, lotions, shampoos, and soaps. While often less stringent than for pharmaceuticals, GMP for cosmetics focuses on preventing microbial contamination, ensuring product stability, and accurately labeling ingredients. The ISO 22716 standard provides specific GMP guidelines for the cosmetic industry, covering production, control, storage, and shipment. | 5. Dietary supplements Covers vitamins, minerals, herbs, and other supplements. GMP ensures that supplements are produced without contaminants, are accurately labeled, and contain the ingredients they claim to. This involves identity testing of raw materials, ensuring proper formulation, and controlling for contaminants like heavy metals and pesticides. In the US, this is governed by 21 CFR Part 111. |
The Qualified Person (QP)
In the European Union, the Qualified Person (QP) serves as the final, legally mandated gatekeeper for every batch of medicinal product.
Before a batch can be released for sale or for use in a clinical trial, a QP must personally certify that it complies with all regulatory requirements. This certification is a formal attestation that the batch was manufactured and tested in accordance with its specific Marketing Authorisation and the principles of Good Manufacturing Practice (GMP). This is not a corporate sign-off; it is a profound personal and legal responsibility placed upon a named individual, who must be a registered professional, such as a pharmacist or chemist, with extensive practical experience.
The QP’s responsibilities extend far beyond the final review of a batch record. They must ensure that the entire Pharmaceutical Quality System is functioning correctly. This includes verifying that all starting materials are from qualified supply chains, that manufacturing and testing processes are properly validated, that all deviations and changes have been appropriately investigated and approved, and that all necessary audits have been performed.
The QP does not personally perform every task, but they are ultimately accountable for the systems that do. They must have a comprehensive understanding of the entire manufacturing and control process, with the authority to access any relevant area or document and the power to halt a release if any aspect of compliance is in doubt.
The rest of this article is reserved for members
To limit scraping bots (currently 40,000 hits per day!),
we had to restrict access to full articles and tools to registered members only.
to access all the rest.
FAQ
In a practical audit, how does an inspector’s expectation for ‘cGMP’ differ from the written ‘GMP’ regulations?
An inspector expects to see not just that you follow your written procedures (GMP), but that your procedures themselves reflect current industry best practices and technology (cGMP). They will question why you are using a 20-year-old analytical method when a more accurate and reliable one is now standard, or why you rely on manual checks where automated in-line verification is now common. They are auditing your awareness and proactive adoption of modern quality standards.
Does cGMP mean we must constantly invest in the newest technology, or can we justify using older, validated equipment?
You can absolutely justify using older equipment, but the burden of proof is on you. Your justification must be documented and risk-based. You need to demonstrate through robust validation, rigorous maintenance, intensive monitoring, and trend data that your older system provides an equivalent or superior level of quality assurance and process control compared to modern alternatives. If your process using old equipment has a higher deviation rate, you will not be able to defend it.
Beyond audit trails, what are the most common ‘unseen’ data integrity gaps regulators are focusing on?
Regulators are heavily scrutinizing uncontrolled spreadsheets used for GMP calculations, the use of shared login credentials on standalone equipment (like balances or pH meters), and the ability to perform “test runs” on analytical equipment that can be deleted without a trace. Another major focus is the integrity of metadata—the data about the data, such as timestamps and user IDs, which must be securely linked to the original record.
How is a Pharmaceutical Quality System (PQS) under ICH Q10 different from just having a strong QA department?
A strong QA department enforces quality; a PQS manages it as a business-wide objective. The key difference is the formal integration of senior management and a focus on process performance and continuous improvement. A PQS ensures that quality metrics directly influence business decisions (like resource allocation and strategic planning) and that management is actively reviewing and driving the system’s effectiveness, as opposed to delegating all quality matters to QA.
What does a “lifecycle approach” to process validation (per ASTM E2500) actually mean for an engineer?
It means validation is no longer a “three-and-done” batch exercise. It’s a continuous process. For an engineer, this means: Stage 1 (Process Design): using Quality by Design (QbD) to define a robust process and its control space. Stage 2 (Process Qualification): verifying the facility and equipment are fit for purpose and that the process consistently works within its defined space (PPQ). Stage 3 (Continued Process Verification): actively monitoring the process during routine production using statistical process control (SPC) to ensure it remains in a state of control for its entire commercial life.
What is the most significant practical difference between EU GMP (EudraLex) and US cGMP?
The most significant difference is the role of the Qualified Person (QP) in the EU. In the US, the Quality Unit has the authority to release a batch. In the EU, a specifically named QP must personally certify that each batch has been manufactured and tested in accordance with all regulations and the marketing authorization before it can be released. This places an immense personal and legal responsibility on one individual.
Our CAPA system is compliant, but problems often recur. What is the cGMP expectation for “CAPA effectiveness”?
The cGMP expectation is that you formally verify your CAPAs worked. This requires building an “effectiveness check” step into your CAPA procedure. This check, performed weeks or months after the CAPA is implemented, must provide objective data (e.g., trend analysis of deviation rates, new audit findings) to prove that the root cause was eliminated and the problem has not recurred. A CAPA closed without this verification is a major red flag for auditors.
How has the cGMP expectation for supplier qualification evolved beyond just auditing the supplier?
Audits are still necessary, but cGMP now expects a more data-driven, risk-based approach. This includes establishing formal Quality Agreements that define responsibilities, monitoring the supplier’s performance through metrics (e.g., on-time delivery, deviation rates, quality of incoming material), and performing periodic raw material testing to verify the supplier’s Certificate of Analysis (CoA). You must demonstrate ongoing oversight, not just a one-time qualification.
With the revision of Annex 1, what is the single biggest cGMP shift in sterile manufacturing?
The biggest shift is the mandate for a formal, holistic Contamination Control Strategy (CCS). This is not just a collection of SOPs but a single, comprehensive document that justifies your facility design, processes, and monitoring programs based on risk management. It forces you to demonstrate how all your individual control measures (from gowning to HVAC to process design) work together to prevent contamination.
Why is Process Analytical Technology (PAT) considered a pillar of modern cGMP?
Because PAT embodies the core cGMP principle of building quality in, rather than testing it in. By providing real-time, in-process data, PAT allows for the active control of Critical Process Parameters (CPPs) to ensure Critical Quality Attributes (CQAs) are met. This shifts manufacturing from a rigid, recipe-based approach to a flexible, science-based model that can adjust to minor variabilities and guarantee a consistent outcome.
How should “human error” be treated as a root cause in a cGMP environment?
In a mature cGMP system, “human error” is rarely an acceptable root cause. It is usually a symptom of a flawed process or system. When an error occurs, the investigation must dig deeper: Was the procedure confusing? Was the training inadequate? Was the workspace poorly designed (human factors engineering)? Was the operator fatigued due to excessive overtime? A robust CAPA will address the underlying system failure, not just retrain the individual.
The Annual Product Review (PQR) is often seen as a chore. What is its intended cGMP purpose?
Its intended purpose is to be a proactive tool for continuous improvement. The PQR should not just be a retrospective data dump. It is a formal opportunity to analyze a year’s worth of data (trends, deviations, changes, stability results) to assess the health and consistency of a process. Its most important output should be a list of recommended CAPAs and process improvements for the upcoming year.
Related Readings
External Links on
International Standards
- ISO 22716:2007 Good Manufacturing Practices (GMP) - Guidelines on Good Manufacturing Practices
- FDA 21 CFR Part 210 and 211: Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs
- ISO 13485:2016 Medical devices - Quality management systems - Requirements for regulatory purposes
(hover the link to see our description of the content)
Glossary of Terms Used
American Society for Testing and Materials (ASTM): an international standards organization that develops and publishes voluntary consensus technical standards for materials, products, systems, and services, aimed at improving quality and safety across various industries.
Application Programming Interface (API): a set of rules and protocols that allows different software applications to communicate and interact with each other, enabling the integration of functionalities and data exchange between systems.
Carbon Capture & Sequestration (CCS): a process that captures carbon dioxide emissions from sources like power plants and industrial processes, transporting it for storage underground or utilizing it in various applications, thereby reducing greenhouse gas concentrations in the atmosphere.
Certificate of Analysis (CoA): a document issued by a manufacturer or testing laboratory that confirms a product's specifications, quality, and compliance with regulatory standards, detailing test results and methods used for analysis.
Contamination Control Strategy (CCS): a systematic approach to prevent, detect, and mitigate contamination in controlled environments, ensuring product quality and safety through defined procedures, monitoring, and risk management practices.
Corrective Action and Preventative Action (CAPA): a systematic approach to identifying, investigating, and addressing nonconformities and potential issues to prevent recurrence and ensure compliance with regulatory standards in quality management systems.
Critical Control Points (CCP): specific stages in a process where control can be applied to prevent, eliminate, or reduce food safety hazards to acceptable levels. Identifying these points is essential for effective hazard analysis and critical control management in food production systems.
current Good Manufacturing Practice (cGMP): a system ensuring that products are consistently produced and controlled according to quality standards, encompassing regulations and guidelines for manufacturing processes, facilities, equipment, and personnel to ensure safety, quality, and efficacy in pharmaceuticals, food, and other regulated industries.
Device History Record (DHR): a compilation of records that documents the production history of a medical device, including manufacturing, quality control, and testing data, ensuring compliance with regulatory requirements and facilitating traceability throughout the device's lifecycle.
Device Master Record (DMR): a compilation of documents and specifications that provide the necessary information to produce a medical device, including design specifications, production processes, quality assurance measures, and labeling requirements, ensuring compliance with regulatory standards.
Failure Mode and Effects Analysis (FMEA): a systematic method for evaluating potential failure modes within a system, process, or product, assessing their effects on performance, and prioritizing risks to improve reliability and safety through corrective actions.
Food and Drug Administration (FDA): a federal agency of the United States Department of Health and Human Services responsible for regulating food safety, pharmaceuticals, medical devices, cosmetics, and tobacco products to ensure public health and safety through scientific evaluation and enforcement of compliance standards.
Good Manufacturing Practice (GMP): a system ensuring products are consistently produced and controlled according to quality standards, minimizing risks involved in pharmaceutical production and related industries. It encompasses guidelines for manufacturing processes, facility conditions, personnel qualifications, and documentation practices to ensure product safety and efficacy.
Hazard Analysis and Critical Control Points (HACCP): a systematic approach to food safety that identifies, evaluates, and controls hazards at critical points in the production process to prevent foodborne illnesses and ensure product safety.
Heating Ventilation and Air Conditioning (HVAC): a system designed to regulate indoor climate by controlling temperature, humidity, and air quality through heating, cooling, and ventilation processes. It includes components such as furnaces, air conditioners, ductwork, and thermostats for efficient environmental management.
Installation Qualification (IQ): a documented process to verify that equipment or systems are installed according to specifications, including assessment of utilities, environmental conditions, and compliance with design requirements, ensuring readiness for operational qualification.
International Organization for Standardization (ISO): a non-governmental international body that develops and publishes standards to ensure quality, safety, efficiency, and interoperability across various industries and sectors, facilitating global trade and cooperation. Established in 1947, it comprises national standardization organizations from member countries.
Key Performance Indicator (KPI): a measurable value that demonstrates how effectively an organization is achieving key business objectives, often used to evaluate success at reaching targets.
Magnetic Resonance Imaging (MRI): a medical imaging technique that uses strong magnetic fields and radio waves to generate detailed images of internal body structures, particularly soft tissues, by detecting the signals emitted from hydrogen nuclei in the presence of a magnetic field.
Operational Qualification (OQ): a validation process that ensures equipment or systems operate according to specified requirements within defined limits, confirming that they perform as intended in their operational environment.
parts per million (ppm): a unit of measurement representing the concentration of one substance in one million parts of another, often used to quantify pollutants or contaminants in air, water, or soil. It is equivalent to milligrams of substance per liter of solution or per kilogram of material.
Performance Qualification (PQ): a process that verifies a system or equipment operates according to specified requirements under real-world conditions, ensuring it consistently performs its intended function within predetermined limits.
Product Lifecycle Management (PLM): a systematic approach to managing a product's lifecycle from inception, through engineering design and manufacturing, to service and disposal, integrating people, processes, data, and technology to improve product quality, reduce time to market, and enhance collaboration across stakeholders.
Qualified Person (QP): an individual with the necessary education, experience, and authority to oversee and ensure compliance with regulatory requirements in the preparation and submission of technical documents, particularly in the mining and resource sectors, as defined by relevant industry standards.
Standard Operating Procedure (SOP): a set of step-by-step instructions created to help workers carry out routine operations consistently and efficiently, ensuring compliance with regulations and quality standards.
Statistical Process Control (SPC): a method of quality control that employs statistical techniques to monitor and control a process, ensuring it operates at its full potential by identifying variations and maintaining consistent output within specified limits.
